Intravesical bacillus Calmette-Guérin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder (Q77507915)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Intravesical bacillus Calmette-Guérin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

transitional cell carcinoma

6 December 2019

main subject

1 reference

J Baniel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

D Grauss

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

D Engelstein

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

A Sella

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

English

0 references

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

785-789

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

Superficial bladder cancer: progression and recurrence

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Results of 6 Weekly Intravesical Bacillus Calmette-Guerin Instillations on the Treatment of Superficial Bladder Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Bacillus Calmette-Guerin Therapy for High Risk Stage T1 Superficial Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Low Dose Pasteur Bacillus Calmette-Guerin Regimen in Stage T1, Grade 3 Bladder Cancer Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Radical cystectomy for historical and pathologic T1, N0, M0 (stage A) transitional cell cancer. Need for adjuvant systemic chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Radical cystectomy--often too late?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

The treated natural history of high risk superficial bladder cancer: 15-year outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Late invasive recurrence despite long-term surveillance for superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

Upper tract transitional cell carcinoma following treatment of superficial bladder cancer with BCG.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900369-0

7 January 2021

10.1016/S0090-4295(98)00369-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9801099%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference